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ABSTRACT 
Objective: To identify and evaluate latent variables (variables that are 
not directly observed) for adopting and using nuclear technologies 
in diagnosis and treatment of chronic diseases. The measurement 
and management of these latent factors are important for healthcare 
due to complexities of the sector. Methods: An exploratory factor 
analysis study was conducted among 52 physicians practicing in the 
areas of Cardiology, Neurology and Oncology in the State of Sao Paulo 
who agreed to participate in the study between 2009 and 2010. Data 
were collected using an attitude measurement questionnaire, and 
analyzed according to the principal component method with Varimax 
rotation. Results: The component matrix after factor rotation showed 
three elucidative groups arranged according to demand for nuclear 
technology: clinical factors, structural factors, and technological 
factors. Clinical factors included questionnaire answers referring to 
medical history, previous interventions, complexity and chronicity 
of the disease. Structural factors included patient age, physician’s 
practice area, and payment ability. Technological factors included 
prospective growth in the use of nuclear technology and availability 
of services. Conclusions: The clinical factors group dimension 
identified in the study included patient history, prior interventions, 
and complexity and chronicity of the disease. This dimension is the 
main motivator for adopting nuclear technology in diagnosis and 
treatment of chronic diseases.
Keywords: Chronic disease; Diagnostic imaging; Therapeutics; Biomedical 
technology; Nuclear medicine; Radioisotopes; Health services administration
RESUMO 
Objetivo: Identificar e avaliar as variáveis latentes (que não podem ser 
observadas diretamente) no processo de adoção e uso de tecnologias 
nucleares no diagnóstico e tratamento de doenças crônicas. A 
mensuração e a gestão dos fatores latentes são importantes 
dentro da área da Saúde devido às complexidades inerentes do 
setor. Métodos: Foi realizado um estudo do tipo fatorial exploratório 
com 52 médicos das especialidades de Cardiologia, Neurologia e 
Oncologia no Estado de São Paulo que participaram do estudo entre 
2009 e 2010. Os dados foram coletados por meio de questionário de 
mensuração de atitudes e analisados pelo método dos componentes 
principais, com rotacionamento do tipo Varimax. Resultados: A 
matriz de componentes após a rotação dos fatores apresentou três 
agrupamentos explicativos ordenados para a demanda de uso das 
tecnologias nucleares: fatores clínicos, fatores estruturais e fatores 
tecnológicos. O fator clínico é formado por respostas referentes a 
histórico clínico, intervenção anterior, complexidade e cronicidade. 
O fator estrutural é composto por idade do paciente, área de atuação 
do médico e capacidade de pagamento; o fator tecnológico diz 
respeito às perspectivas de aumento do uso da tecnologia nuclear – 
quantidade de serviços. Conclusões: A dimensão de fatores clínicos 
é composta por histórico clínico, intervenção anterior, complexidade 
e cronicidade da doença. Essa dimensão é o principal motivador 
para adoção da tecnologia nuclear no diagnóstico e tratamento das 
doenças crônicas. 
Descritores: Doença crônica; Diagnóstico por imagem; Terapêutica; 
Tecnologia biomédica; Medicina nuclear; Radioisótopos; Administração 
de serviços de saúde 
INTRODUCTION 
The adoption and diffusion of technology in hospitals 
and healthcare organizations rely on the knowledge 
and perception that the agents – physicians, nurses 
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and other healthcare professionals – have about this 
technology. The healthcare sector was extremely 
benefited from technological advances that helped 
promote survival of patients and cure of diseases 
once considered as fatal. The growth in the use of 
technologies in this area has been of fundamental 
importance to maintaining this progress; however, 
the technology adoption process does not occur 
immediately, nor should it. This process should be 
guided by a consistent decision-making process, to 
ensure a sensible use of the institutional resources. 
This decision-making must also meet the expected 
success in adopting the technology, i.e., it is too costly a 
failure when a technology is not perceived as adequate 
by the agents that potentially will be using it.
In view of these issues, an empirical study was 
conducted aiming to identify latent variables to 
complement the decision-making process on technology 
adoption. In this study, a statistical exploratory factor 
analysis was used to combine the subjects of chronic 
diseases and the use of nuclear technology in their 
diagnosis and treatment. As chronic diseases, we 
considered those with a low risk of life in the short 
term, although they may result in severe conditions and 
require prolonged medical attention(1). 
This selection was based on the scenario of a 
growing importance of chronic diseases in the disease 
burden of developing countries. In these countries, 
the increasing prevalence of chronic diseases is a 
concern for companies, organizations, and individuals. 
The main reasons for this concern are the high costs 
generated by these diseases for public health systems 
and private sectors, as well as the impact on the quality 
of life of the individuals affected by these conditions. 
Heart diseases, cancer, and neurological diseases are 
the main causes of deaths and disabilities in general 
populations.
 A partial explanation for the increase in the chronic 
disease burden is the advancement in treatment of 
infectious diseases. In Brazil, these diseases account 
for 66% of the disease burden, and the remainder 
is attributed to communicable diseases (24%), and 
accidents (10%)(2). Another reason may be the change 
in the epidemiological profile of the populations of 
developing countries. This is a consequence of multiple 
factors, such as increased urbanization, improvement 
in healthcare measures against infectious diseases, and 
lifestyle changes, involving nutrition, smoking habit, 
alcohol consumption, and regular physical activity(3,4). 
In Brazil, the regions with the highest chronic disease 
burden are the South and Southeast regions, with 70 
and 69%, respectively. The North and Northeast regions 
also present high DALY (disability-adjusted life years) 
rates due to infectious diseases.
While selecting technology, we observed that 
nuclear technology can help alleviate the effects of 
chronic diseases through non-invasive procedures for 
diagnosis and staging of diseases such as cancer. Besides, 
nuclear technology can also be used in patients suffering 
from certain neurological disorders and heart diseases. 
According to the study of the Committee on State of 
the Science of Nuclear Medicine, of 2007(5), clinical 
applications of nuclear medicine include the following: 
(I) diagnosis of diseases like cancer, neurological 
disorders (e.g. Alzheimer’s and Parkinson’s), and 
cardiovascular diseases in their early stages, allowing 
early treatment and reducing morbidity and mortality, 
(II) non-invasive access for therapeutic measures, 
reducing patient exposure to toxic treatments and 
allowing early initiation of treatment, (III) treatment 
for cancer and certain endocrine disorders (thyroid and 
neuroendocrine tumors).
Advancement in patient health care is complex and 
slow. The expansion in the development of nuclear 
medicine techniques has the potential to expedite, 
simplify and reduce healthcare costs, and may facilitate 
the implementation of personalized medicine. These 
factors demonstrate the dynamics of nuclear medicine 
in the current context. With the introduction and 
diffusion of hybrid devices, such as PET/CT, there was 
an increase in the use and accuracy of diagnostic imaging 
by nuclear medicine. These methods combine metabolic 
and anatomic information to determine the extent and 
severity of certain diseases, and more accurately identify 
relative risks and improve monitoring of the patient. 
In the context of the study, despite the technological 
advances related to chronic diseases, developments are 
also needed to understand the process of internalization 
of new technologies and the perceived factors for use 
and dissemination.
OBJECTIVE 
The objective of this study was to identify factors 
not directly observable, which nonetheless influence 
the decision-making process on the use of nuclear 
technologies for diagnosis or treatment of chronic 
diseases. The study also evaluated which were the group 
dimensions of the factors that were identified. 
METHODS
The perception of the agents was measured using a 
five-point Likert attitude scale, ranging from “Strongly 
Disagree” to “Strongly Agree”. The success of this scale 
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is the fact that it is sensitive to retrieve Aristotelian 
concepts of demonstration of quality, because it 
recognizes the conflict between opposites, the gradient, 
and the intermediate situation. Another advantage is 
the proper relation between precision and accuracy of 
measurements(6).
Data collection was conducted between March 
and November 2009. Cardiologists, oncologists, and 
neurologists that directly or indirectly make use of 
nuclear technology for diagnosis and/or treatment of 
chronic diseases participated in this data collection. 
The samples were selected from the group of members 
of the Brazilian Cardiology Society, Brazilian Society of 
Oncology and Regional Medical Board of Sao Paulo. 
The final sample used in the analysis comprised 52 
physicians practicing the aforementioned medical 
specialties in the metropolitan area of the city of Sao 
Paulo, in the region of ABC Paulista, in municipalities 
of the Vale do Paraiba region, in municipalities of the 
region of Campinas, in the municipalities of the region 
of Ribeirao Preto and in the region of Sorocaba. 
Exploratory factor analysis and principal components 
analysis are statistical techniques applied to a single 
set of variables when the researcher seeks to find out 
which variables form coherent subsets and are relatively 
independent of one another. The correlated variables, 
which are largely independent of other subsets of 
variables, are combined into factors that form the 
structures that tend to reflect the underlying processes 
by the correlations among variables.
RESULTS
No multicollinearity in factors was observed using the 
determinant of the correlation matrix (0.19). Therefore, 
the dimensionality of the correlation matrix of results 
was reduced, and the variables that were highly 
correlated with each other were grouped in factors 
(Table 1).
The factors obtained determined the dimensions: 
clinical, structural, and technological. The size of the 
sample that gave rise to factors was adequate (0.7), 
having been checked by the Kaiser-Meyer-Olkin 
(KMO) test, and the intercorrelation was assessed by 
Bartlett’s test of sphericity (p <0.001). Vectors were 
selected as important by the Guttman-Kaiser criterion 
for latent values greater than one. 
Therefore, the first component explained 32.154% 
of the variance observed. The second component is 
based on the residual correlation, and is the linear 
combination of the observed variables which extracts 
the maximum variance among those uncorrelated 
with the first component. The other components also 
extract the maximum variance based on the residual 
correlations and are orthogonal to the components 
extracted. Table 2 shows the components of the matrix 
after the rotation of factors. Loadings with values 
smaller than 0.4(7) were excluded from the analysis and 
the remaining values  were sorted by size. 
The clinical factors include answers regarding the 
medical history, previous interventions, and complexity 
and chronicity of the disease. The structural factors 
comprise answers related to the patient’s age, the 
physician’s medical specialty, and payment ability. 
The technological factors include answers referring to 
the prospects of increased nuclear technology use in 
diagnosis and treatment, and the number of nuclear 
medicine services installed in the location of the 
respondent.
Table 1. Table of eigenvalues  and sums 
Initial eigenvalues Extraction sums of  squared loadings
Rotation sums of  
squared loadings
Components Total Variance (%)
Cumulative 
variance  
(%)
Total Variance (%)
Cumulative 
variance
 (%)
Total Variance (%)
Cumulative 
variance  
(%)
1 3.21 32.15 32.15 3.21 32.15 32.15 3.18 31.80 31.80
2 1.70 17.04 49.20 1.70 17.04 49.20 1.67 16.79 48.59
3 1.50 14.99 64.20 1.50 14.99 64.20 1.56 15.60 64.20
4 0.90 9.07 73.27
5 0.82 8.21 81.49
6 0.67 6.76 88.25
7 0.46 4.60 92.85
8 0.38 3.84 96.69
9 0.20 2.02 98.71
10 0.12 1.28 100.00
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Table 3 shows the correlation matrix extracted using 
principal components analysis and rotated using the 
Varimax method with Kaiser normalization. The table 
suggests an interdependence of factors.
that demand for the use of nuclear technology in 
diagnosis and treatment of chronic diseases depends 
primarily on the patient’s clinical condition, followed 
by structural factors and prospects for development 
and technological availability. As to the perception 
of agents, the demand must prioritize the results 
that might be obtained by the available or potential 
technology. Similarly, a new technology may also 
have slower adoption if the agents’ perceptions of the 
clinical aspects cannot be satisfied on a priority basis. 
Thus, while the expectations of growth in the number of 
chronic diseases pose a serious problem for the next 
few years(2,3), especially given the higher probability 
of hospitalization of patients affected by this type of 
disease. The factors referred to as “clinical” should be 
taken into consideration in the adoption process of a 
technology, so it can offer a return within an efficient 
frontier. The use of structured information can lead to 
a more efficient process of technological diffusion and 
mitigate the risks of spending on economically costly 
artifacts if they do not meet expectations. In the last 
century, among the main achievements of medicine 
were the development of clinical epidemiology and 
a partial control of infectious diseases. In the first 
decade of this century, chronic diseases are emerging 
as a major area of  attention. And as in the last 
century, today’s challenges can benefit from the use of 
technology to bring solutions to new problems.
CONCLUSION
The study showed an important approach to healthcare 
management and technology adoption, considering the 
exploratory factor analysis as an aid in determining the 
perception of agents. The emergence and change in 
social conditions of diseases also create new demands, 
which should be considered together. Therefore, medical 
technology and the social conditions of the disease 
should be observed together, since technology itself 
does not represent a guarantee that it will be a useful 
tool in diagnosis and treatment. When technologies are 
acquired without a real assessment of the perception of 
agents, this may lead to underutilization and therefore 
to a loss of financial resources to properly deal with the 
issue, especially considering the problem of agency. 
The analysis process developed in this study can be 
applied to other technologies and health conditions that 
permeate healthcare organizations. 
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